Kinoxis Therapeutics
Melbourne, AU · Founded 2017 · 18 employees on LinkedIn · 2 known investors
Find your way into Kinoxis Therapeutics
86 people in our graph share verified history with the Kinoxis Therapeutics team — schools, employers, funds. One of them is your warm intro.
Tim Heasleyunlockedknows Hugh Alsop · together at University of Melbourne (overlapped)
×4knows the team · via University of Melbourne
×2knows the team · via Hatchtech Pty Ltd
×5knows the team · via Melbourne Business School
Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.
Founders & leadership
Kinoxis Therapeutics was founded in 2017 by Hugh Alsop and Michael Bowen.
HA
Hugh AlsopinChief Executive Officer, Co-FounderHugh Alsop is Chief Executive Officer and co-founder of Kinoxis Therapeutics, a clinical-stage Australian biotech company developing small-molecule therapeutics for central nervous system disorders. He holds a Bachelor of Science in Chemistry from the University of Melbourne and an MBA from Melbourne Business School, and brings over 25 years of pharmaceutical and biotechnology executive experience across drug development, commercialisation, and business development roles at companies including Mayne Pharma, Acrux Limited, and Phosphagenics.
MB
Michael BoweninChief Scientific Officer, Co-Founder
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BAug 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Kinoxis Therapeutics do?
- Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.
- Who founded Kinoxis Therapeutics?
- Kinoxis Therapeutics was founded by Hugh Alsop, Michael Bowen in 2017.
- Who are Kinoxis Therapeutics's investors?
- Kinoxis Therapeutics's investors include Stoic VC, UniSeed Pty Ltd..
- Where is Kinoxis Therapeutics headquartered?
- Kinoxis Therapeutics is headquartered in Melbourne, AU.